These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22642541)

  • 21. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterocyclic ring scaffolds as small-molecule cholesterol absorption inhibitors.
    Ritter T; Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Biomol Chem; 2005 Oct; 3(19):3514-23. PubMed ID: 16172689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezetimibe in hypercholesterolaemia.
    Farnier M
    Int J Clin Pract; 2002 Oct; 56(8):611-4. PubMed ID: 12425372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular pathways and agents for lowering LDL-cholesterol in addition to statins.
    Costet P
    Pharmacol Ther; 2010 Jun; 126(3):263-78. PubMed ID: 20227438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of ketoconazole on the cholesterol content of the blood serum lipoproteins and bile in experimental hypercholesterolemia].
    Dushkin MI; Ivanova MV
    Eksp Klin Farmakol; 1992; 55(2):47-9. PubMed ID: 1422455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.
    Howell KL; DeVita RJ; Garcia-Calvo M; Meurer RD; Lisnock J; Bull HG; McMasters DR; McCann ME; Mills SG
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6929-32. PubMed ID: 21030254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.
    Altmann SW; Davis HR; Zhu LJ; Yao X; Hoos LM; Tetzloff G; Iyer SP; Maguire M; Golovko A; Zeng M; Wang L; Murgolo N; Graziano MP
    Science; 2004 Feb; 303(5661):1201-4. PubMed ID: 14976318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezetimibe treatment of pediatric patients with hypercholesterolemia.
    Clauss S; Wai KM; Kavey RE; Kuehl K
    J Pediatr; 2009 Jun; 154(6):869-72. PubMed ID: 19230898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats.
    Yamamoto T; Ito K; Honma M; Takada T; Suzuki H
    Drug Metab Dispos; 2007 Sep; 35(9):1455-8. PubMed ID: 17567728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of melatonin on cholesterol absorption in rats.
    Hussain SA
    J Pineal Res; 2007 Apr; 42(3):267-71. PubMed ID: 17349025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
    Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
    Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Niemann-pick C1-like 1 mediates alpha-tocopherol transport.
    Narushima K; Takada T; Yamanashi Y; Suzuki H
    Mol Pharmacol; 2008 Jul; 74(1):42-9. PubMed ID: 18403720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.
    Goel RK; Thind JS; Bal CS; Mahajan MP; Kulkarni SK
    Pharmazie; 2005 May; 60(5):369-74. PubMed ID: 15918588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.